Bitolterol Mesylate

CHEMBL1200405 Phase 4 已批准 Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
557.7 g/mol
LogP
Phase
4

The mesylate salt of bitolterol, a bronchodilator prodrug that relaxes the airways to ease breathing in asthma and COPD. Once inhaled, it is converted by lung enzymes into the active beta-2 agonist colterol. This agent is no longer commercially available.

分子量

557.7000 g/mol

TPSA

148.00 Ų

作用机制

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

机制

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

二维结构

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CS(=O)(=O)O.Cc1ccc(C(=O)Oc2ccc(C(O)CNC(C)(C)C)cc2OC(=O)c2ccc(C)cc2)cc1

InChI

InChI=1S/C28H31NO5.CH4O3S/c1-18-6-10-20(11-7-18)26(31)33-24-15-14-22(23(30)17-29-28(3,4)5)16-25(24)34-27(32)21-12-8-19(2)9-13-21;1-5(2,3)4/h6-16,23,29-30H,17H2,1-5H3;1H3,(H,2,3,4)

Molecular Formula

C29H35NO8S

HBD / HBA

3 / 9

可旋转键数

10

重原子数

39

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

常见问题

The mesylate salt of bitolterol, a bronchodilator prodrug that relaxes the airways to ease breathing in asthma and COPD. Once inhaled, it is converted by lung enzymes into the active beta-2 agonist colterol. This agent is no longer commercially available.

Activates beta-2 adrenergic receptors on bronchial smooth muscle, stimulating adenylyl cyclase and increasing intracellular cAMP. This relaxes airway smooth muscle and produces bronchodilation.

Yes, Bitolterol Mesylate is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200405. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 35329. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

医疗免责声明

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.